General data: NMR spectra were recorded on a Brucker 400 MHz spectrometer. Mass spectra were recorded on a Thermo LTQ Orbitrap XL (ESI + ). Infrared spectra were recorded on a Nicolet MX-1E FTIR spectromter. HPLC analysis was performed on Waters-Breeze (2487 Dual λ Absorbance Detector and 1525 Binary HPLC Pump, UV detection monitored at 205 nm or 254 nm).
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General procedure for tryptamine derivatives
A mixture of tryptamine (5 mmol) and Et 3 N (6 mmol) in CH 2 Cl 2 (40 mL) was stirred at 0 °C, and then FmocCl (7 mmol) was added with a spoon. The reaction mixture was stirred at room temperature until the reaction was complete (the reaction time was 1-4 hours). The resultant solution was washed with water and extracted with EtOAc. The combined organic layers were washed with brine and dried over anhydrous Na 2 SO 4 . The crude product was purified through flash column chromatography on silica gel (eluent: petroleum ether:ethyl acetate = 4:1-2:1) to yield pure products (Fmoc-2-(1H-indol-3-yl)ethylcarbamate), yield 84%.
To a mixture of Fmoc-2-(1H-indol-3-yl)ethylcarbamate (4 mmol) and Bu 4 NHSO 4 (0.8 mmol) in CH 2 Cl 2 (30 mL) were sequentially added Ac 2 O (8 mmol) and aqueous NaOH solution (2 mol/L, 5 mL) at 0 °C via sryinge. The reaction mixture was stirred at room temperature until the reaction was complete (the reaction time was 5-15 minutes; the Fmoc group would be removed for a long time). The resultant solution was poured into a mixture of water and EtOAc (1/1 ratio). The aqueous layer was extracted with EtOAc (3 × 40 mL). The combined organic layers were washed with brine and dried over anhydrous Na 2 SO 4 . The crude product was purified through flash column chromatography on silica gel (eluent: petroleum ether:ethyl acetate = 3:1-2:1) to give products (Fmoc-2-(1-acetyl-1H-indol-3-yl) ethylcarbamate), yield: 91%.
(9H-Fluoren-9-yl)methyl 2-(1-acetyl-1H-indol-3-yl)ethylcarbamate (1a).
1 H NMR (CDCl 3 , 400 MHz) δ (ppm): 2.57 (s, 3H), 2.93 (m, 2H), 3.56 (m, 2H), 4.20 (t, J = 6.72 Hz, 1H), 4.43 (d, J = 6.72 Hz, 2H), 4.88 (m, 1H), 7.28 (m, 4H), 7.39 (m, 3H), 7.55 (m, 3H), 7.75 (d, J = 7.52 Hz, 2H), 8.43 (d, J = 8.04 Hz, 1H) .
(9H-Fluoren-9-yl)methyl 2-(1-acetyl-6-fluoro-1H-indol-3-yl)ethylcarbamate (1b). 7.63 (s, 1H), 7.75 (d, J = 7.52 Hz, 2H), 8.30 (d, J = 8.8 Hz, 1H) .
(9H-Fluoren-9-yl)methyl 2-(1-acetyl-5-methoxy-1H-indol-3-yl)ethylcarbamate (1d). 8, 34.6, 45.8, 46.5, 55.7, 66.7, 83.8, 115.9, 119.4, 120.0, 124.9, 125.3, 126.7, 127.0, 127.6, 129.1, 129.6, 131.5, 135.3, 136.7, 140.7, 140.8, 141.0, 143.4, 143.6, 153.6, 169.4; Enantiomeric excess: 86%, determined by HPLC (Daicel Chirapak IA-H, hexane/isopropanol = 70/30, flow rate 1.0 mL/min, T = 30 °C, 254 nm ): t R = 11.93 min(minor), t R = 25.89 min(major); IR (KBr): 2921, 2858, 1740, 1709, 1652, 1507, 1362, 1248, 1166, 831, 755, 699 8, 34.7, 45.7, 46.6, 66.6, 84.2, 117.3 120.0, 124.3, 124.9, 125.3, 125.4, 127.0, 127.6, 129.1, 129.6, 131.8, 132.5, 132.8, 136.6, 140.7, 142.8, 143.4, 143.6, 153.6, 169.6; Enantiomeric excess: 83%, determined by HPLC (Daicel Chirapak IA-H, hexane/isopropanol = 70/30, flow rate 1.0 mL/min, T = 30 °C, 254 nm ): t R = 9.14 min(minor), t R = 17.04 min(major); IR (KBr): 2921, 2858, 1740, 1709, 1652, 1507, 1362, 1248, 1166, 831, 755, 699 8, 34.6, 45.8, 46.5, 55.8, 66.7, 83.9, 119.0, 120.0, 122.9, 123.8, 124.9, 125.3, 127.0, 127.6, 128.1, 128.7, 129.1, 129.6, 132.6, 134.2, 136.7, 140.7, S5 143.4, 143.6, 153.6, 169. 8, 34.7, 45.7, 46.6, 66.6, 84.2, 117.3 120.0, 124.3, 124.9, 125.3, 125.4, 127.0, 127.6, 129.1, 129.6, 131.8, 132.5, 132.8, 136.6, 140.7, 142.8, 143.4, 143.6, 153.6, 169. 8, 34.6, 45.8, 46.5, 55.8, 66.7, 83.9, 119.0, 120.0, 122.9, 123.8, 124.9, 125.3, 127.0, 127.6, 128.1, 128.7, 129.1, 129.6, 132.6, 134.2, 136.7, 140.7, 143.4, 143.6, 153.6, 169 8, 34.6, 45.8, 46.5, 55.8, 66.7, 83.9, 119.0, 120.0, 122.9, 123.8, 124.9, 125.3, 127.0, 127.6, 128.1, 128.7, 129.1, 129.6, 132.6, 134.2, 136.7, 140.7, 143.4, 143.6, 153.6, 169 6, 26.9 ,46.0, 47.1, 63.5, 67.4, 115.3, 116.6, 118.8, 120.0, 123.4, 123.5, 124.6, 124.9, 127.0, 127.1, 127.7, 129.1, 132.7, 134.2, 138.6, 141.3, 142.6, 143.7, 154.4, 160.2, 168 A mixture of N-phenylselenophthalimide (N-PSP) (3 mmol, 902 mg), catalyst 3b (0.1 mmol, 70 mg), Fmoc-Ac-tryptamine (2 mmol, 850 mg), and 5 Å molecular sieves (500 mg) was added to a Schlenk tube, and the tube was flushed with argon gas three times. Then, the DCE (20 mL) was added at 0 °C. The reaction mixture was stirred at 0 °C until the reaction was complete (the reaction time was 5 d, monitored by TLC). The reaction mixture was extracted with CH 2 Cl 2 (3 × 20 mL).
The combined organic layers were dried over anhydrous Na 2 SO 4 , and concentrated in vacuo. The S8 residue was purified by flash column chromatography (petroleum ether:ethyl acetate = 6:1-4:1) on silica gel to give the product 4a (930 mg, 80% yield, 82% ee). After a single recrystallization from methanol, the product 4a was obtained in 50% yield and with 97% ee. To a solution of 4a (500 mg, 0.86 mmol) and K 2 CO 3 (469 mg, 3.4 mmol) in DCM (30 mL) was added wet MCPBA (70%) (1.0 g, 5 mmol) at room temperature. Afterward, the reaction was stirred at room temperature for 10 mins, brine was added, and then the crude mixture was extracted with 4, 39.6, 46.4, 47.2, 67.5, 84.6, 119.1, 120.0, 123.2, 123.5, 124.8, 125.2, 127.1, 127.2, 127.8, 127.9, 130.8, 134.2, 141.3, 141.4, 142.4, 143.5, 154.4, 168.1, 170.8; IR (KBr): 2930 , 2854 , 1745 , 1740 , 1652 , 1507 , 1362 , 1248 , 1166 
Synthesis of (3aS
